vs
BUCKLE INC(BKE)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
BUCKLE INC的季度营收约是REPLIGEN CORP的1.6倍($320.8M vs $197.9M),BUCKLE INC净利率更高(15.2% vs 6.7%,领先8.5%),REPLIGEN CORP同比增速更快(13.6% vs 9.3%),BUCKLE INC自由现金流更多($38.4M vs $17.6M)
Buckle Inc.是美国时尚零售企业,面向全年龄段消费者销售服饰、鞋履及配饰。目前在美国42个州运营451家门店,品牌包括Buckle和The Buckle,产品涵盖知名品牌及自有品牌服饰,含牛仔装、休闲下装、上衣、连衣裙、运动休闲服饰、外套、鞋类、泳装、香氛及箱包配饰等。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
BKE vs RGEN — 直观对比
营收规模更大
BKE
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出4.4%
9.3%
净利率更高
BKE
高出8.5%
6.7%
自由现金流更多
BKE
多$20.8M
$17.6M
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $320.8M | $197.9M |
| 净利润 | $48.7M | $13.3M |
| 毛利率 | 48.0% | 52.5% |
| 营业利润率 | 19.0% | 9.0% |
| 净利率 | 15.2% | 6.7% |
| 营收同比 | 9.3% | 13.6% |
| 净利润同比 | 10.3% | 143.9% |
| 每股收益(稀释后) | $0.96 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BKE
RGEN
| Q4 25 | $320.8M | $197.9M | ||
| Q3 25 | $305.7M | $188.8M | ||
| Q2 25 | $272.1M | $182.4M | ||
| Q1 25 | $379.2M | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | — | $154.9M | ||
| Q2 24 | — | $154.1M | ||
| Q1 24 | — | $151.3M |
净利润
BKE
RGEN
| Q4 25 | $48.7M | $13.3M | ||
| Q3 25 | $45.0M | $14.9M | ||
| Q2 25 | $35.2M | $14.9M | ||
| Q1 25 | $77.2M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | — | $-654.0K | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率
BKE
RGEN
| Q4 25 | 48.0% | 52.5% | ||
| Q3 25 | 47.4% | 53.2% | ||
| Q2 25 | 46.7% | 50.0% | ||
| Q1 25 | 52.6% | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
BKE
RGEN
| Q4 25 | 19.0% | 9.0% | ||
| Q3 25 | 18.4% | 8.9% | ||
| Q2 25 | 16.0% | 7.6% | ||
| Q1 25 | 25.4% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率
BKE
RGEN
| Q4 25 | 15.2% | 6.7% | ||
| Q3 25 | 14.7% | 7.9% | ||
| Q2 25 | 12.9% | 8.2% | ||
| Q1 25 | 20.4% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益(稀释后)
BKE
RGEN
| Q4 25 | $0.96 | $0.24 | ||
| Q3 25 | $0.89 | $0.26 | ||
| Q2 25 | $0.70 | $0.26 | ||
| Q1 25 | $1.54 | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $24.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $510.7M | $2.1B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
BKE
RGEN
| Q4 25 | $24.0M | $767.6M | ||
| Q3 25 | $22.1M | $748.7M | ||
| Q2 25 | $22.9M | $708.9M | ||
| Q1 25 | $23.8M | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务
BKE
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
BKE
RGEN
| Q4 25 | $510.7M | $2.1B | ||
| Q3 25 | $476.2M | $2.1B | ||
| Q2 25 | $445.3M | $2.1B | ||
| Q1 25 | $423.8M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产
BKE
RGEN
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.0B | $2.9B | ||
| Q2 25 | $977.3M | $2.9B | ||
| Q1 25 | $913.2M | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比
BKE
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $49.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $17.6M |
| 自由现金流率自由现金流/营收 | 12.0% | 8.9% |
| 资本支出强度资本支出/营收 | 3.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.02× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $215.3M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
BKE
RGEN
| Q4 25 | $49.4M | $25.7M | ||
| Q3 25 | $58.4M | $48.1M | ||
| Q2 25 | $31.0M | $28.6M | ||
| Q1 25 | $120.8M | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | — | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流
BKE
RGEN
| Q4 25 | $38.4M | $17.6M | ||
| Q3 25 | $46.4M | $43.4M | ||
| Q2 25 | $19.6M | $21.5M | ||
| Q1 25 | $111.0M | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率
BKE
RGEN
| Q4 25 | 12.0% | 8.9% | ||
| Q3 25 | 15.2% | 23.0% | ||
| Q2 25 | 7.2% | 11.8% | ||
| Q1 25 | 29.3% | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度
BKE
RGEN
| Q4 25 | 3.4% | 4.1% | ||
| Q3 25 | 3.9% | 2.5% | ||
| Q2 25 | 4.2% | 3.9% | ||
| Q1 25 | 2.6% | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率
BKE
RGEN
| Q4 25 | 1.02× | 1.93× | ||
| Q3 25 | 1.30× | 3.23× | ||
| Q2 25 | 0.88× | 1.92× | ||
| Q1 25 | 1.56× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图